Skip to main content
  • Visisonics Hits Market with 3-D Sound Technology

     

    Technology Spun from University of Maryland Currently Licensed by Oculus

    Read More
  • Profectus BioSciences Initiates Ebola Vaccine Phase 1 Clinical Trial

    Phase 1 trial will Evaluate the Safety and Immunogenicity of Profectus' Ebola Virus Vaccine Administered at Various Dose Levels

    Read More
  • Harpoon Medical could sell to new investor, Edwards Lifesciences

    Read More
  • UMB GRANTS PATAIGIN, LLC, RIGHTS TO DEVELOP TECHNOLOGY FOR RAPID IDENTIFICATION OF DANGEROUS PATHOGENS

    Read More
  • Remedy Pharmaceuticals Completes $9 Million Financing

    Round was led by several new investors and included participation from existing investors

    Read More
  • Remedium Technologies Receives FDA Clearance for Hemogrip™ Patch

    Technology Rapidly Controls Bleeding at Vascular Access Sites

    READ MORE
  • Hot Technologies Available for Licensing

    UM Ventures is organized to move research outcomes into products and services, tools and diagnostics that will benefit society.

    Learn More

Upcoming Events

Receive Tech Alerts

Sign up to receive the UM Ventures e-newsletter, new technology announcements, and other news.

Select Your Interest(s)

Proudly showcasing UM Ventures Companies

In the last two years, UM Ventures has increased technology licenses by 46 percent (28 in FY11 vs. 41 in FY13) and new startup companies created by UM faculty increased by 120 percent (5 in FY11 to 11 in Fy13).

University of Maryland, College Park
University of Maryland, Baltimore

UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.

Learn More